Comparison of CREB- and NF-κB-Mediated Transactivation by Human T Lymphotropic Virus Type II (HTLV-II) and Type I (HTLV-I) Tax Proteins  by Lewis, Martha J. et al.
Virology 295, 182–189 (2002)Comparison of CREB- and NF-B-Mediated Transactivation by Human T Lymphotropic Virus
Type II (HTLV-II) and Type I (HTLV-I) Tax Proteins
Martha J. Lewis,*,† Noreen Sheehy,* Marco Salemi,‡ Anne-Mieke VanDamme,‡ and William W. Hall*,1
*Department of Medical Microbiology, Conway Institute of Biomolecular and Biomedical Research, University College Dublin,
Belfield, Dublin 4, Ireland; †Rockefeller University, New York, New York 10021; and ‡Rega Institute for Medical Research
and University Hospitals, B-3000 Leuven, Belgium
Received September 10, 2001; returned to author for revision November 2, 2001; accepted January 3, 2002
The function of the transactivator protein Tax from HTLV-II subtype A, subtype B, Brazilian subtype C, and African subtype
D isolates was compared to that of Tax from an HTLV-I isolate. HTLV-II subtypes A, B, and C were less active in the
transactivation of a NF-B reporter compared to HTLV-I Tax in 293T but not Jurkat T cells. In both cell types there were no
significant differences between the functions of HTLV-II B, C, and D and HTLV-I Tax proteins on either a full-length HTLV-I
LTR or a 21-bp repeat reporter, suggesting that there is equivalent CREB-mediated transactivation between the viruses and
these subtypes. In contrast, Tax of some but not all HTLV-II subtype A isolates, including the prototype Mo, had a greatly
decreased ability to transactivate, and this could be directly correlated with a decrease in protein expression. Employment
of cDNA clones encoding both Rex and Tax demonstrated that Rex was unable to rescue the expression or activity of the
IIA Mo isolate. These studies demonstrate that with the exception of some HTLV-IIA subtypes there are no significant
differences in Tax transactivation via the CREB and NF-B pathways between the two viruses and suggest that the HTLV-IIINTRODUCTION
Human T lymphotropic viruses type I (HTLV-I) and type
II (HTLV-II) are closely related human retroviruses which
have a preferential in vivo tropism for CD4 and CD8 T
lymphocytes, respectively (Hall et al., 1996; Ijichi et al.,
1992; Poiesz et al., 1993; Richardson et al., 1990). HTLV-I
has been clearly established as a human pathogen, and
infection is associated with the development of adult T
cell leukemia/lymphoma (ATLL) and a progressive neu-
rological disease known as HTLV-I-associated myelopa-
thy/tropical spastic paraparesis (HAM/TSP) (Gessain et
al., 1985; Manns et al., 1999; Osame et al., 1987; Takat-
suki et al., 1985). In contrast, the association of HTLV-II
infection with specific clinical disorders remains less
clearly defined; however, there is accumulating evidence
that HTLV-II is associated with the development of neu-
rological, and possibly lymphoproliferative, disorders
(Berger et al., 1991; Harrington et al., 1993; Jacobson et
al., 1993; Kaplan et al., 1991; Poiesz et al., 2000; Rosen-
blatt et al., 1988b).
Although the mechanisms involved in the pathogene-
sis of HTLV-related disorders remain incompletely under-
stood the viral transcriptional activator protein Tax ap-
pears to play a central role (Green and Chen, 1994). The© 2002 Elsevier Science (USA)
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182Tax protein of both HTLV-I and II is able to regulate
transcription from both the viral long terminal repeat
(LTR) and host cell promoters. Tax mediates its effects
not by directly binding DNA, but by interacting at various
levels in host cell transcription factor pathways (Fuji-
sawa et al., 1991). Tax activates transcription from the
viral LTR via its interaction with CREB and activates
transcription of numerous cellular genes involved in im-
mune regulation via its interaction with the NF-B path-
way (Armstrong et al., 1993; Bex and Gaynor, 1998; Yo-
shida et al., 1995). HTLV-I Tax can transform and immor-
talize primary lymphocytes in culture, and HTLV-II Tax
has also been shown to be necessary for the transfor-
mation of T lymphocytes (Akagi et al., 1995; Grassman et
al., 1992; Ross et al., 1996; Tanaka et al., 1990). Moreover,
HTLV-II Tax mutants deficient in either NF-B or CREB/
ATF activation function were unable to transform primary
human T cells (Ross et al., 2000), highlighting the crucial
role of transactivation by Tax via these pathways in the
pathogenesis of lymphoproliferative disorders.
HTLV-I Tax (Tax-I) and HTLV-II Tax (Tax-II) share 73–
75% nucleotide sequence homology and 72–74% homol-
ogy at the amino acid level (Cann and Chen, 1996).
Among the different subtypes of HTLV-I the Tax proteins
are homogeneous insofar as all isolates encode a pro-
tein of equal length. In contrast, the Tax proteins of theTax may have a pathogenic potential equivalent to that of
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different subtypes of HTLV-II are rather heterogeneous
(Figs. 1A and 1B). HTLV-I Tax and HTLV-II subtypes B andHTLV-I.
cular b
on
C Tax are approximately equal in length, having 353 and
356 amino acids, respectively, although the C-terminal
sequences of the proteins are quite divergent (Eiraku et
al., 1996; Pardi et al., 1993; Seiki et al., 1983). HTLV-II
subtype A Tax completely lacks this C-terminal portion of
the protein as a stop codon truncates the protein at 331
amino acids (Pardi et al., 1993; Shimotohno et al., 1985).
Although the C-terminal amino acids missing from the
shorter HTLV-IIA protein do not appear to be essential for
transactivation (Lewis et al., 2000; Semmes et al., 1996),
they do contain a major epitope for humoral immune
recognition (Lewis et al., 2000; Pardi et al., 1993). HTLV-II
subtype D, which was isolated from an African pygmy,
encodes a Tax protein of 344 amino acids that as yet
remains uncharacterized (Vandamme et al., 1998).
Previous reports describing the relative function of
HTLV-I and II Tax proteins have utilized only the shorter
HTLV-II Tax protein (Semmes et al., 1996; Shah et al.,
1986), and other studies of the relative function of the
heterogeneous HTLV-II Tax proteins have made no com-
parison with respect to HTLV-I Tax (Eiraku et al., 1996).
Therefore in order to assess the relative transactivation
function of all the known HTLV-II Tax proteins relative to
HTLV-I, we have constructed a series of FLAG-tagged
Tax constructs (Fig. 1C) and three luciferase reporter
constructs, containing NF-B response elements, the
HTLV-I LTR, or only the 21-bp repeat elements from the
viral LTR. Constructs were transiently transfected into
either 293T cells or Jurkat T cells. We report here that
there are no consistently significant differences in either
NF-B- or CREB-mediated transactivation, with the ex-
ception of certain HTLV-IIA Tax isolates which appear to
have a generalized deficiency to transactivate owing to a
decreased level of protein expression relative to the
other Tax isolates.
RESULTS
Comparison of HTLV-II and HTLV-I Tax function
Tax expression plasmids were transiently transfected
into either 293T or Jurkat cells along with a luciferase
reporter construct in order to assess the ability of each
subtype to activate transcription. Two separate controls
were employed to normalize assay results relative to
transfection efficiency and these revealed no more than
5% variability in efficiency among the different constructs
(data not shown). Each of the FLAG-tagged Tax con-
structs was transfected into 293T cells at amounts rang-
ing from 0.125 to 2.5 g while the amount of the 21-bp
repeat reporter construct (p21) was kept constant (Fig.
2A). The activity of each construct was found to increase
proportionally with the amount of transfected DNA ex-
cept for the HTLV-IIA construct, Mo, which did not sig-
nificantly transactivate this reporter at any level. Using an
NF-B–luciferase reporter construct and 293T cells (Fig.
2B) it could be shown that each of the HTLV-II subtype A,
B, and C Tax proteins was significantly less active than
HTLV-I Tax, whereas the HTLV-II subtype D Tax was not
significantly different (P values of 0.01, 0.006, 0.01, and
0.09, respectively). However, each of the HTLV-II Tax
proteins with the exception of the HTLV-II subtype A
isolate Mo was equally able to increase transcription
from either tandem copies of the 21-bp repeats or the full
HTLV-I LTR (Fig. 2B) (P values of 0.04, 0.08, 0.27, 0.42 and
0.02, 0.09, 0.07, 0.27, respectively). Similar results were
obtained using Jurkat T cells and the 21-bp repeat re-
FIG. 1. Description of Tax isolates and clones. (A) A neighbor-joining
tree constructed from a 996-nt fragment of the tax gene and evaluated
by 100 bootstrap replicates schematically demonstrates the subtypes
A–D of the HTLV-II Tax isolates. STLV-PP1664 was used to root the tree,
and HTLV-I ATK-1 was used as a reference sequence. The correspond-
ing length of the Tax protein is indicated in boldface type following the
name and subtype of each isolate. (B) Alignment of C-terminal amino
acids of each different Tax protein with sequence positions as noted.
(C) Each of the expression clones is shown in relation to the viral
mRNA; the scale is given at the top. The features of the viral mRNA are
denoted by the following: positions of LTR sequences are labeled
“5LTR” and “3LTR,” respectively; RRE, HTLV-II Rex-responsive ele-
ment; “SJ1” and “SJ2” are splice junctions 1 and 2, respectively; “21”
indicates the presence of the three 21-bp repeats in the 3LTR; and rex
and tax start and stop codons are as indicated. “FLAG” refers to the
presence of an N-terminal FLAG epitope.
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porter (Fig. 2C) where again only the HTLV-IIA Tax was
significantly less active than HTLV-I Tax (P values of 0.03,
0.10, 0.10, and 0.12). In contrast, cotransfection of the
NF-B reporter in Jurkat T cells (Fig. 2C) revealed no
significant differences among any of the isolates (P val-
ues of 0.85, 0.20, 0.30, and 0.10, respectively). Finally, Tax
constructs without epitope tags were cotransfected into
293T cells along with the 21-bp repeat reporter (Fig. 2D),
and it was again demonstrated that only HTLV-IIA Tax
was significantly less active than HTLV-I Tax (P value of
0.005). The transactivation properties of the HTLV-I and II
Tax proteins using the complete HTLV-II LTR in the re-
porter construct were also compared. Results obtained
were similar to those for the HTLV-I LTR in that, with the
exception of the HTLV-IIA Mo, the HTLV-I and -IIB, C, and
D Tax proteins could all increase transcription from the
HTLV-II LTR at equivalent levels (data not shown).
Analysis of Tax expression
To compare expression levels, FLAG epitope-tagged
constructs were employed so that antibodies would rec-
ognize each of the Tax proteins with the same affinity as
opposed to the employment of specific anti-Tax antibod-
ies which may recognize some subtypes better than
others. Immunoprecipitation followed by immunoblot of
the Tax proteins revealed that the HTLV-IIA Mo is ex-
pressed at greatly reduced levels in comparison to the
FIG. 2. Functional comparison of Tax isolates. All values are expressed as fold activation over the vector alone and are normalized according to
transfection efficiency as described under Materials and Methods. (A) Each of the FLAG-Tax constructs was cotransfected into 293T cells along with
0.5 g of the p21-luc. reporter. The amount of transfected Tax plasmid ranged from 0.125 to 2.5 g. Results represent the mean of at least two
experiments. (B) 2.5 g of each FLAG-Tax construct was cotransfected into 293T cells with 0.5 g of pNF-B-luc., p21-luc., or HTLV-I-LTR-luc., as
indicated. Results represent the mean of at least five separate experiments. A Student’s T test was used to determine significant differences from
HTLV-I Tax. * P value  0.05. (C) 2.5 g of each FLAG-Tax construct was cotransfected into Jurkat cells with 0.5 g of either pNF-B-luc. or p21-luc.,
as indicated. (D) 2.5 g of each pCAGGS-Tax construct was cotransfected into 293T cells with 0.5 g of p21-luc. Results represent the mean of at
least three experiments. Statistical testing was as in (B).
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others when the total amount of protein in each sample
is kept constant (Fig. 3A). RT-PCR was carried out in
order to determine whether the decrease in Tax expres-
sion occurred at a transcriptional or posttranscriptional
level. Although the RT-PCR was not strictly quantitative,
equal amounts of total RNA were used in each reaction,
and it was observed that all Tax messages are present in
relatively equal amounts (Fig. 3B).
Comparison of the function of HTLV-II subtype A
isolates
In order to determine whether the observed decreased
expression and function is a general feature of HTLV-IIA
Tax proteins or whether it may be possibly a result of the
truncation of the C-terminus we compared the function of
several other HTLV-IIA isolates as well as a deletion
mutant where the additional C-terminal amino acids
present in subtype IIB and IIC isolates had been re-
moved (Fig. 4). Isolate SP-WV from Brazil belongs to the
subtype A clade as shown in Fig. 1A, but it encodes a Tax
protein which is 25 amino acids longer and has been
designated as subtype C to highlight this difference
(Eiraku et al., 1996). Full-length SP-WV Tax has significant
function and is well expressed. Deletion of the extended
sequence resulting in a subtype A construct of the same
length as Mo yields a protein which is both well ex-
pressed and functional. Additionally, we compared the
function of Tax from two other subtype A isolates, Gal
and CG. While CG was both well expressed and func-
tional, isolate Gal behaved similarly to Mo in that it was
neither well expressed nor functional although mRNAs
from all these subtype A constructs were equally detect-
able (Fig. 4).
Comparison of cDNA-like clones
Previous studies on HTLV-IIa Mo utilizing a cDNA
clone which contained Tax and Rex coding sequences
as well as a portion of the 3LTR showed significant
levels of transactivation (Ross et al., 1996, 1997). We
constructed a series of cDNA-like clones in order to
assess the relative contribution of the various regions to
overall transactivation. Initially, the 3LTR region follow-
ing the tax stop codon was deleted and a polyhistidine
epitope was added in its place. This deletion was found
to result in an improvement in Tax function relative to the
parent construct probably because the 3LTR contains
the 21-bp repeats and possibly competed with the lucif-
erase reporter (data not shown). A Mo cDNA-like poly-
cistronic clone beginning with the rex start codon and
ending with the tax stop codon was found to have sig-
nificant function compared to the Tax only clone. Like-
wise, each of the other HTLV-II cDNA constructs dis-
played relative increases in function but without accom-
panying increases in Tax expression (Fig. 5). We were
unable to detect the histidine-tagged Mo Tax construct
using the same conditions employed for the other Tax
subtypes. Immunoprecipitation and Western blot with
anti-FLAG antibodies to detect Rex revealed that Rex is
also expressed from these cDNA clones. However, since
Tax proteins were detected without immunoprecipitation
and the Rex proteins were first precipitated, it is difficult
to comment on the relative expression levels of the two
proteins from the cDNA constructs.
FIG. 4. Comparison of multiple HTLV-IIA Tax isolates. 293T cells
were transfected with 2.5 g of each FLAG–Tax construct. (A) Cells
were cotransfected with 0.5 g of either p21-luc. (open bars) or pNF-
B-luc. (striped bars) and luciferase activity is expressed as the fold
activation over vector alone. Results represent the mean of at least
three experiments and are normalized according to transfection effi-
ciency. (B) Analysis of tax expression is as in Fig. 3. (Top) An anti-FLAG
Western blot following immunoprecipitation by anti-FLAG M2 antibody.
(Middle) A specific 996-nt fragment of HTLV-II tax amplified by RT-PCR.
(Bottom) A -actin control RT-PCR.
FIG. 3. Analysis of tax gene expression. 293T cells were transfected
with 2.5 g of FLAG-Tax plasmid and lysed after 40 h. (A) Tax was
immunoprecipitated with anti-FLAG M2 monoclonal antibody and then
Western blot was performed using anti-FLAG M5 monoclonal antibody.
(B) 0.1 g of DNase I-treated total RNA was used as template for
RT-PCR. A 1059- or 996-nt fragment is specific for HTLV-I or HTLV-II tax,
respectively. -Actin served as a control for template quantity and
integrity.
185COMPARISON OF HTLV-I AND HTLV-II TAX PROTEINS
DISCUSSION
In the present study we describe for the first time a
comparison of the relative transactivation function and
expression levels of Tax isolates from the four known
molecular subtypes of HTLV-II with that of HTLV-I. It
could be shown that most HTLV-II Tax proteins indepen-
dent of the virus subtype are able to activate transcrip-
tion from both NF-B- and CREB-mediated pathways at
levels not statistically different from HTLV-I Tax, and
particularly when tested in T cells. The only exceptions
were Tax proteins from certain HTLV-IIA isolates which
exhibited poor transactivation activity, and our studies
suggest that this was due to low levels of protein ex-
pression. RT-PCR analysis, while not strictly quantitative,
demonstrated that Tax mRNAs were present in relatively
equal amounts. Thus it is likely that the observed differ-
ences in Tax protein expression are not due to significant
differences in transcriptional efficiency or message sta-
bility. However, further studies are required to establish
whether rates of translation or turnover may differ. It is
possible that Tax expression may not be similarly af-
fected in vivo in the context of a complete provirus.
Previous studies utilizing a cDNA clone of HTLV-II Mo
Tax showed significant activity, and therefore the trans-
activation function of several cDNA clones was tested.
Proportional increases in Tax function without corre-
sponding increases in expressed protein were detected
for each of the cDNA clones. As with the Tax only ex-
pression constructs, the HTLV-IIA Mo cDNA construct
was less active than either the HTLV-IIB or the HTLV-IIC
cDNA isolate. Although the coexpression of Rex protein
is likely to contribute indirectly to the increased transac-
tivation function, it also appeared that the removal of the
N-terminal FLAG epitope led to an increase in Tax func-
tion (W.W.H., unpublished results).
It is currently unclear whether the differences in Tax
activity in vitro may be reflected in vivo. To date, HTLV-II
infection has not been consistently associated with the
development of ATLL-like malignant processes like
those seen with HTLV-I infection. Thus it is possible that
additional activities of Tax other than those involving
NF-B and CREB pathways also contribute to transfor-
mation. HTLV-I Tax has been shown to be extremely
pleiotropic and can interact with a range of other tran-
scription factors and a large number of proteins involved
in cell cycle regulation. Further studies should determine
whether similar interactions also occur with Tax of the
various HTLV-II subtypes. In this regard we have in
preliminary studies found that both the HTLV-IIA and B
Tax proteins are capable of binding important cell cycle
and transcriptional regulatory proteins, such as IKK-
(W.W.H., unpublished observation), in the same manner
as has been reported for HTLV-I Tax (Jin et al., 1999). It is
also possible that interactions with proteins such as
IKK- may account for HTLV-IIA Tax’s ability to increase
transcription via the NF-B pathway in Jurkat cells at a
level equivalent to the other isolates despite lower levels
of protein expression. It is also likely that in addition to
the activities of Tax that other factors, both viral and host
factors, may be important in transformation. In this re-
gard it is possible that other viral regulatory proteins may
contribute to the development of lymphoid malignancies
and differences may well exist between HTLV-I and II.
It should be noted that there is not a strict correlation
between HTLV-II subtype and Tax protein length. For
example, all Brazilian isolates to date belong to the
subtype A clade, yet encode the longer 356-aa. Tax
protein typical of subtype B isolates (Lewis et al., 2000)
and for this reason we refer to these isolates as subtype
C. However, there is also at least one report of a subtype
B isolate from a Seminole Indian from Florida encoding a
short 331-aa Tax protein typical of subtype A isolates
(Pardi et al., 1993). We have also demonstrated that not
all short HTLV-IIA Tax proteins exhibit similar lower lev-
els of expression. In the present study we observed that
Tax proteins from two HTLV-IIA isolates from non-Amer-
indians were poorly expressed, but in contrast the iso-
late from an Amerindian displayed activity equivalent to
that of all other subtypes. Although no conclusions can
be drawn from such a limited number of isolates, it may
be informative to analyze the function of a larger number
of isolates from both Amerindians and non-Amerindians
involving all subtypes in order to determine whether
there is a significant correlation. Detailed comparisons
FIG. 5. Comparison of cDNA and Tax only clones. 293T cells were
transfected with 2.5 g of FLAG-Tax or cDNA-like clones. (A) Cells were
cotransfected with 0.5 g of p21-luc. Luciferase activity is expressed as
fold activation over vector alone. Results represent the mean of at least
three experiments and are normalized according to transfection effi-
ciency. (B) Western blot using anti-GST-TaxIIB without immunoprecipi-
tation to detect Tax either with or without the FLAG epitope (top) and
anti-FLAG M5 Western blot following immunoprecipitation by anti-
FLAG M2 antibody to detect the FLAG-tagged Rex protein expressed
from the cDNA-like clones (bottom).
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of protein sequence throughout the entire Tax protein
may provide important clues to understanding the stabil-
ity of the protein and the levels of expression. These and
additional studies will ultimately allow a thorough under-
standing of the pathogenic properties of the Tax proteins
of the two viruses.
MATERIALS AND METHODS
Origin of Tax isolates and phylogenetic analysis
The HTLV-I isolate PMT-2 was from a cloned provirus,
a variant produced from the MT-2 cell line. The HTLV-II
isolates Gal, Mo, and Gar are from North America, Gal
and Gar being from intravenous drug users (IVDUs).
Isolate CG is from an Amerindian in New Mexico (Hjelle
et al., 1993). SP-WV is from an IVDU from Sa˜o Paolo,
Brazil (Lewis et al., 2000) and Efe2 is from an African
pygmy (Vandamme et al., 1998). A 996-nt fragment of the
tax coding region from each of these sequences was
aligned and edited using MacClade 3.05. The phyloge-
netic tree was constructed using a neighbor-joining al-
gorithm as implemented by PHYLIP v.3.572 (Felsenstein,
1989). The phylogeny was evaluated using 100 molecular
bootstrap replicates. STLV isolate PP1664 was used as
an outgroup and the HTLV-I isolate ATK-1 was also
added for reference. Accession numbers are as follows:
PMT-2, AF292000; Gal, AF292002; Mo, M10060; Gar,
AFO292001; CG, M63881; SP-WV, AF139382; Efe2,
Y14365; PP1664, Y14570; ATK-1, J02029.
Plasmid constructs
All Tax coding sequences were cloned into pFLAG-
CMV2 (Kodak-Eastman, Rochester, NY) using the HindIII
and EcoRI restriction sites or pCAGGS (Niwa et al., 1991)
using the EcoRI site unless otherwise noted (see Fig. 1).
Tax sequences were amplified from DNA templates from
either cloned proviruses, infected PBMCs or established
cultures using the following primers: Tax forward H3,
5AAGCTTATGGCCCATTTCCCAGG3; Tax forward RI,
5GGAATTCCATGGCCCATTTCCCAGG3; Tax1 reverse,
5GGAATTCCTCAGACTTCTGTTTCTCG3; Tax2A reverse,
5GGAATTCCCTAGTCGCCATTGTCATC3; Tax2B/C re-
verse, 5GGAATTCCTTACTTGGGATTGTTTGTG3; Tax2D
reverse, 5GGAATTCCTTAGGCCGATGACTCGTC3. The
SP-WV 331 deletion mutant was generated by PCR
using the Tax forward and Tax 2A reverse primers. HTLV-
IIA CG and Mo Tax were amplified from plasmid con-
structs 264 and PG104, respectively (kindly provided by
O. J. Semmes (Semmes et al., 1996) and P. L. Green, Ohio
State University) using Tax forward and Tax2A reverse
primers (as above). All PCRs were carried out in a Per-
kin–Elmer 9600 series thermocycler, and mixtures con-
tained 0.001–1 g template DNA, a 225 M concentra-
tion of each deoxyribnucleoside triphosphate, a 100 pM
concentration of each primer, 50 mM KCl, 2 mM MgCl2,
10 mM Tris–HCl (pH 8.3), and 2.0 U PfuTurbo (Strat-
agene) in a total volume of 100 l. The PCR conditions
were as follows: initial denaturation at 94°C for 5 min,
followed by 35 amplification cycles of 1 min at 94°C, 1
min at 54.5°C, and 2 min at 72°C, followed by a final
extention at 72°C for 10 min.
Reporter constructs p21x5-luc and pNF-Bx4-luc. were
kindly provided by T. Akagi and Shimotono, Kyoto Uni-
versity, Japan. The HTLV-I LTR was amplified, using PCR
conditions as above, from pH5KA (kindly provided by H.
Hasegawa, NIID, Tokyo, Japan), using the following prim-
ers: LTR1 for., 5AAGCTTTGACAATGACCATGAGCCCC3
and LTR1 rev., 5TCGCGATGTGTACTAAGTTTCTCTCC3.
The PCR fragment was cloned into the HindIII and NruI
sites of pGL3 (Promega). All constructs generated by
PCR were checked by thorough sequencing to confirm
the accuracy of each clone.
Cell culture and transfections
293T cells were maintained in DMEM supplemented
with 10% FCS and antibiotics. Cells were seeded into
6-well plates the day prior to transfection. Jurkat cells
were cultured in RPMI plus 10% FCS and antibiotics and
were diluted to 0.8  106/ml the day prior to transfection.
Jurkat cells were transfected in the presence of 10% FCS
using FuGene 6 reagent (Boehringer Mannheim) accord-
ing to the manufacturer’s recommendations. After 24 h
PHA was added to the cultures at a concentration of 100
g/ml and culture continued for another 24 h. 293T cells
were transfected with Lipofectamine (Gibco BRL). Trans-
fection mixtures contained 0.125–5.0 g Tax or Rex plas-
mid and 0.5 g luciferase reporter plasmid in OptiMEM
(Gibco BRL). Empty vector was added to each mixture in
order to keep the final concentration of transfected DNA
equal. To check for equal transfection efficiency among
the Tax constructs each plasmid was cotransfected in
the presence of pHM6lacZ (Boehringer Mannheim), and
after 40 h cells were fixed in 4% paraformaldehyde and
stained with X-gal to detect -galactosidase expression.
As an additional control for transfection efficiency, cells
were cultured in medium without phenol red indicator
and each Tax plasmid was cotransfected with a lucif-
erase reporter and AP-Tag4 (Cheng et al., 1995), which
encodes a secreted form of heat-stable alkaline phos-
phatase (AP). After 40 h supernatants were heated to
65°C for 15 min to deactivate any endogenous AP, as-
sayed by the addition of P-NPP ELISA substrate (Moss,
Inc.), and incubated at 37°C for 15 min, and the OD405
was read. The cells were lysed and assayed for lucif-
erase activity and all readings were normalized relative
to the AP levels.
Luciferase assays
Cells were lysed in Reporter Lysis Buffer (Promega)
and incubated on ice for 20 min before centrifugation at
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12,000 g for 1 min at 4°C. Supernatants were assayed at
room temperature for luciferase activity using Promega’s
Luciferase Assay System and a Turner Designs 20-20
Luminometer. A Student’s T test was used to statistically
evaluate the difference with respect to HTLV-I Tax func-
tion.
Immunoprecipitation and Western blot
Cells were lysed in buffer containing 50 mM Tris, pH
7.5, 150 mM NaCl, 0.5% sodium deoxycholate, 1% NP-40,
0.1% SDS, and protease inhibitors (Boehringer Mann-
heim). Tax was immunoprecipitated from lysates using
1.0 g M2 anti-FLAG murine monoclonal antibody
(Sigma) and 35 l agarose–Protein G (Boehringer Mann-
heim) in a total volume of 1 ml for 4 h at 4°C. Complexes
were washed five times in increasingly stringent buffers.
All samples were analyzed on 12% SDS–PAGE. Proteins
were transferred to PVDF, which was then probed with
either M5 anti-FLAG murine monoclonal antibody or a
rabbit anti-HTLV-IIb-Tax-GST polyclonal antibody. HRP-
conjugated secondary antibody and ECL (Amersham)
were used for detection. Anti-His (C-term) antibody (In-
vitrogen) was used to detect C-terminal tagged Tax con-
structs.
RT-PCR
293T cells were seeded into 6-well plates and trans-
fected with 2.5 g FLAG-Tax or empty vector using Lipo-
fectamine (Gibco BRL). After 40 h cells were lysed in 1 ml
of TRIzol reagent (Gibco BRL) and total RNA was ex-
tracted according to the manufacturer’s instructions.
DNase I (Boehringer Mannheim) was added to 2 g of
total RNA for 30 min at room temperature and then 0.1 g
was used as template. RT-PCR master mix was prepared
using the SuperScript RT-PCR system (Gibco BRL) with
the primers Tax forward and Tax2A or Tax1 reverse
(sequences are as above). RT was carried out for 30 min
at 50°C followed by 35 cycles of PCR, 15 s at 94°C, 45 s
at 55°C, 2 min at 68°C, and a final extension of 10 min at
72°C.
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